INSIGHTS ON CLINICAL TRIAL DESIGN

• Is Your Clinical Research Site GCP-Ready?

  By fostering a culture of continuous improvement through internal audits, clinical research sites can identify non-compliance issues and enhance their research practices.

• Clinical Trial Support: Point Of Need vs. Traditional Solutions

  Examine the limitations of traditional, fixed-location ophthalmic trial sites and how a mobile assessment model can significantly improve patient retention while ensuring high-quality data collection.

• GA Screening: Early Detection For Future Trial Recruitment

  Community-based screenings identify undiagnosed eye disease at high rates, creating a scalable, high-trust pathway for early intervention and improved clinical research recruitment.

• Receptor Occupancy In The Era Of Multispecific Therapeutics

  Receptor occupancy studies face new challenges as multispecific therapeutics introduce complex target engagement, receptor trafficking, cellular interactions, and assay interpretation considerations.

• 5 Strategies For Designing Successful Complex Rare Disease Trials

  3/31/2026

  Rare disease trials demand inventive design. Uncover creative strategies that help sponsors overcome tiny populations, complex endpoints, and operational hurdles to advance meaningful breakthroughs.

• Why Early Clinical Development Is Shifting Toward Decision-Enabling Study Designs

  6/9/2026

  Early clinical research is shifting to decision-focused designs, using biomarkers, functional endpoints, and targeted populations to reduce uncertainty and enable clearer progression.

• Elevating The Site Voice

  3/27/2025

  A decentralized trial can be daunting for sites, but Medidata offers solutions to help site staff, sponsors, and patients move smoothly through the clinical trial process.

• Defining And Implementing The Right Oncology Digital Strategy

  11/7/2024

  A panel of oncology experts shares how top life science companies are using a combination of DHTs, ePROs, clinical trial platforms, and more to ease oncology research and drastically reduce timelines.

• Factors Affecting Systemic Drug Exposure

  1/22/2025

  The increasing number of drugs on the market leads to a greater potential for DDIs. Determining the extent of the interaction and associated risks is an important safety consideration.